|
US5470571A
(en)
|
1988-01-27 |
1995-11-28 |
The Wistar Institute |
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
|
|
FR2660556B1
(fr)
|
1990-04-06 |
1994-09-16 |
Rhone Poulenc Sante |
Microspheres, leur procede de preparation et leur utilisation.
|
|
IL98528A0
(en)
|
1990-06-21 |
1992-07-15 |
Merck & Co Inc |
Pharmaceutical compositions containing hybrid for killing bladder cancer cells
|
|
AU658396B2
(en)
|
1991-03-06 |
1995-04-13 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Humanized and chimeric monoclonal antibodies
|
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
CA2086874E
(en)
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
|
US6306421B1
(en)
|
1992-09-25 |
2001-10-23 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
WO1999000113A1
(en)
|
1997-06-27 |
1999-01-07 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US5665382A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5362478A
(en)
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
CA2155947C
(en)
|
1993-02-22 |
2007-08-21 |
Mark W. Grinstaff |
Methods for in vivo delivery of biologics and compositions useful therefor
|
|
US5994341A
(en)
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
|
DE69403966T3
(de)
|
1993-07-19 |
2008-04-17 |
Angiotech Pharmaceuticals, Inc., Vancouver |
Anti-angiogene mittel und verfahren zu deren verwendung
|
|
US6441026B1
(en)
|
1993-11-08 |
2002-08-27 |
Aventis Pharma S.A. |
Antitumor compositions containing taxane derivatives
|
|
AU1831395A
(en)
|
1994-01-14 |
1995-08-01 |
Cell Therapeutics, Inc. |
Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
|
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
|
US5662883A
(en)
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
|
US5534270A
(en)
|
1995-02-09 |
1996-07-09 |
Nanosystems Llc |
Method of preparing stable drug nanoparticles
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US6565842B1
(en)
|
1995-06-07 |
2003-05-20 |
American Bioscience, Inc. |
Crosslinkable polypeptide compositions
|
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
|
US5744460A
(en)
|
1996-03-07 |
1998-04-28 |
Novartis Corporation |
Combination for treatment of proliferative diseases
|
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
|
PL189698B1
(pl)
|
1996-03-12 |
2005-09-30 |
Pg Txl Co |
Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
|
|
DE69736750T2
(de)
|
1996-07-30 |
2007-08-16 |
Novartis Ag |
Pharmazeutische zusammensetzungen zur behandlung der transplantatabstossung sowie der autoimmun- oder entzündlichen zustände
|
|
CA2263765C
(en)
|
1996-08-19 |
2010-03-30 |
Vivorx Pharmaceuticals, Inc. |
Methods for the production of protein particles useful for delivery of pharmacological agents
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
DE69829891T2
(de)
|
1997-04-07 |
2005-10-06 |
Genentech, Inc., South San Francisco |
Anti-VEGF Antikörper
|
|
US20030199425A1
(en)
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US6258084B1
(en)
|
1997-09-11 |
2001-07-10 |
Vnus Medical Technologies, Inc. |
Method for applying energy to biological tissue including the use of tumescent tissue compression
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
ES2279614T3
(es)
|
1998-04-16 |
2007-08-16 |
Eurovita A/S |
Nuevas composiciones sinergicas que contienen compuestos aromaticos y terpenoides presentes en alpinia galanga.
|
|
IL141155A0
(en)
|
1998-07-30 |
2002-02-10 |
Human Rt |
Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
|
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
|
AU777528B2
(en)
|
1999-04-22 |
2004-10-21 |
Abraxis Bioscience, Llc |
Long term administration of pharmacologically active agents
|
|
CA2371912C
(en)
|
1999-05-21 |
2010-02-16 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
KR20070058028A
(ko)
|
1999-05-24 |
2007-06-07 |
소너스파머슈티칼즈인코포레이티드 |
난용성 약물용 에멀젼 부형제
|
|
WO2001034174A2
(en)
|
1999-11-12 |
2001-05-17 |
Entremed, Inc. |
Methods for administration of therapeutic agents on an antiangiogenic schedule
|
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
|
CZ20023333A3
(cs)
|
2000-04-10 |
2003-06-18 |
Teva Pharmaceutical Industries Ltd. |
Léčivo pro léčení rakoviny
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
CA2413134C
(en)
|
2000-06-30 |
2010-05-11 |
Glaxo Group Limited |
Quinazoline ditosylate salt compounds
|
|
US6946456B2
(en)
|
2000-07-28 |
2005-09-20 |
Sloan-Kettering Institute For Cancer Research |
Methods for treating cell proliferative disorders and viral infections
|
|
JP2004525860A
(ja)
|
2000-09-22 |
2004-08-26 |
ブリストル−マイヤーズ スクイブ カンパニー |
併用化学療法剤の毒性を低下させる方法
|
|
US7141576B2
(en)
|
2001-01-16 |
2006-11-28 |
Smithkline Beecham (Cork) Limited |
Cancer treatment method
|
|
US6548531B2
(en)
|
2001-02-09 |
2003-04-15 |
Hoffmann-La Roche Inc. |
Method for cancer therapy
|
|
GB0103668D0
(en)
|
2001-02-15 |
2001-03-28 |
Biointeractions Ltd |
Methods and clinical devices for the inhibition or prevention of mammalian cell growth
|
|
US6770653B2
(en)
|
2001-03-06 |
2004-08-03 |
Bristol-Myers Squibb Company |
Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
|
|
WO2002069949A2
(en)
*
|
2001-03-06 |
2002-09-12 |
Prendergast Patrick T |
Combination therapy for reduction of toxycity of chemotherapeutic agents
|
|
US6752922B2
(en)
|
2001-04-06 |
2004-06-22 |
Fluidigm Corporation |
Microfluidic chromatography
|
|
US7638161B2
(en)
|
2001-07-20 |
2009-12-29 |
Applied Materials, Inc. |
Method and apparatus for controlling dopant concentration during BPSG film deposition to reduce nitride consumption
|
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
|
US20040033271A1
(en)
|
2001-12-03 |
2004-02-19 |
Seth Lederman |
Methods for contemporaneous administration of levamisole and 5-fluorouracil
|
|
US20040143004A1
(en)
|
2002-02-26 |
2004-07-22 |
Joseph Fargnoli |
Metronomic dosing of taxanes
|
|
ITMI20020681A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
ITMI20020680A1
(it)
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
|
US20040126400A1
(en)
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
|
US7794743B2
(en)
|
2002-06-21 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Polycationic peptide coatings and methods of making the same
|
|
TWI272273B
(en)
|
2002-07-16 |
2007-02-01 |
Sonus Pharma Inc |
Platinum compounds
|
|
EA200500234A1
(ru)
|
2002-08-19 |
2005-08-25 |
Пфайзер Продактс Инк. |
Комбинированная терапия гиперпролиферативных болезней
|
|
US20040047835A1
(en)
*
|
2002-09-06 |
2004-03-11 |
Cell Therapeutics, Inc. |
Combinatorial drug therapy using polymer drug conjugates
|
|
US20050095267A1
(en)
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
|
KR20140148502A
(ko)
|
2002-12-09 |
2014-12-31 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
|
DK1585548T3
(en)
|
2002-12-09 |
2018-09-03 |
Abraxis Bioscience Llc |
COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS
|
|
AU2004204778B2
(en)
|
2003-01-10 |
2008-05-22 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer with 2-deoxyglucose
|
|
EP1643971A2
(en)
|
2003-05-22 |
2006-04-12 |
Neopharm, Inc. |
Liposomal formulations comprising a combination of two or more active agents
|
|
RS20150135A1
(sr)
|
2003-05-30 |
2015-08-31 |
Genentech Inc. |
Tretman sa anti-vegf antitelima
|
|
AR046510A1
(es)
|
2003-07-25 |
2005-12-14 |
Regeneron Pharma |
Composicion de un antagonista de vegf y un agente anti-proliferativo
|
|
AU2004273910A1
(en)
*
|
2003-09-18 |
2005-03-31 |
Combinatorx, Incorporated |
Combinations of drugs for the treatment of neoplasms
|
|
EA200600495A1
(ru)
|
2003-09-23 |
2006-10-27 |
Новартис Аг |
Комбинация ингибитора vegf рецептора с химиотерапевтическим агентом
|
|
WO2005039533A1
(en)
|
2003-10-15 |
2005-05-06 |
Medigene Ag |
Method of administering cationic liposomes comprising an active drug
|
|
US20080045559A1
(en)
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
CA2543722C
(en)
|
2003-10-29 |
2011-01-04 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US7129368B2
(en)
|
2004-03-15 |
2006-10-31 |
Sonus Pharmaceuticals, Inc. |
Platinum carboxylate anticancer compounds
|
|
WO2006001911A2
(en)
|
2004-05-06 |
2006-01-05 |
Genentech, Inc. |
Crystal structure of the hepatocyte growth factor beta chain and methods of use
|
|
ES2529660T3
(es)
|
2004-05-14 |
2015-02-24 |
Abraxis Bioscience, Llc |
Métodos de tratamiento en los que se utilizan las proteínas de unión a albúmina como dianas
|
|
US8420603B2
(en)
|
2004-05-14 |
2013-04-16 |
Abraxis Bioscience, Llc |
SPARC and methods of use thereof
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
SG183012A1
(en)
|
2004-06-04 |
2012-08-30 |
Genentech Inc |
Method for treating multiple sclerosis
|
|
SV2006002143A
(es)
|
2004-06-16 |
2006-01-26 |
Genentech Inc |
Uso de un anticuerpo para el tratamiento del cancer resistente al platino
|
|
US8772269B2
(en)
|
2004-09-13 |
2014-07-08 |
Eisai R&D Management Co., Ltd. |
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
CN103169729A
(zh)
|
2005-02-18 |
2013-06-26 |
阿布拉科斯生物科学有限公司 |
治疗剂的组合和给予方式以及联合治疗
|
|
WO2006112930A2
(en)
|
2005-02-18 |
2006-10-26 |
Abraxis Bioscience, Inc. |
Q3 sparc deletion mutant and uses thereof
|
|
KR20070114774A
(ko)
|
2005-02-28 |
2007-12-04 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
술폰아미드 화합물의 혈관 신생 저해 물질과의 신규 병용
|
|
CA2601067A1
(en)
|
2005-05-04 |
2006-11-09 |
Medigene Ag |
Method of administering a cationic liposomal preparation comprising paclitaxel
|
|
US20080221135A1
(en)
|
2005-05-13 |
2008-09-11 |
Bristol-Myers Squibb Company |
Combination therapy
|
|
US7566716B2
(en)
|
2005-05-20 |
2009-07-28 |
Array Biopharma Inc. |
Imidazopyrazines as Raf inhibitor compounds
|
|
CN101291658B
(zh)
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
|
US7771751B2
(en)
|
2005-08-31 |
2010-08-10 |
Abraxis Bioscience, Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
|
WO2007059116A2
(en)
|
2005-11-14 |
2007-05-24 |
Abraxis Bioscience, Inc. |
Geldanamycin derivatives and pharmaceutical compositions thereof
|
|
CA2646156C
(en)
|
2006-03-22 |
2016-05-24 |
Medigene Ag |
Treatment of triple receptor negative breast cancer
|
|
US20080086337A1
(en)
|
2006-08-10 |
2008-04-10 |
Patrick Soon-Shiong |
Web based integrated information system for sharing patient medical information cross-organizationally
|
|
US20080280987A1
(en)
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
AU2006347740A1
(en)
|
2006-08-31 |
2008-03-06 |
Abraxis Bioscience, Llc |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
US9675578B2
(en)
|
2006-12-14 |
2017-06-13 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
FR2912839B1
(fr)
|
2007-02-16 |
2009-05-15 |
Soitec Silicon On Insulator |
Amelioration de la qualite de l'interface de collage par nettoyage froid et collage a chaud
|
|
EP3417859A1
(en)
|
2007-03-07 |
2018-12-26 |
Abraxis BioScience, LLC |
Nanoparticle comprising rapamycin and albumin as anticancer agent
|
|
WO2008137148A2
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Methods and compositions for treating pulmonary hypertension
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
US20090018078A1
(en)
|
2007-07-09 |
2009-01-15 |
Vinod Labhasetwar |
Apoptosis-Modulating Protein Therapy for Proliferative Disorders and Nanoparticles Containing the Same
|
|
WO2009089098A1
(en)
*
|
2008-01-03 |
2009-07-16 |
Musc Foundation For Research Development |
Methods for the treatment of cancers
|
|
WO2009126175A1
(en)
|
2008-04-10 |
2009-10-15 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
CA2721153C
(en)
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
AU2009324464B2
(en)
|
2008-12-11 |
2016-05-05 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
BRPI1008955A2
(pt)
|
2009-03-13 |
2015-09-01 |
Abraxis Bioscience Llc |
Terapia de combinação com derivados de tiocolchicina.
|
|
MX2011010673A
(es)
|
2009-04-10 |
2012-02-21 |
Abraxis Bioscience Llc |
Formulaciones de nanoparticulas y usos de las mismas.
|
|
HRP20192259T1
(hr)
|
2009-04-15 |
2020-03-06 |
Abraxis Bioscience, Llc |
Pripravci nanočestica bez priona i metode njihove proizvodnje
|
|
BR112012004149A2
(pt)
*
|
2009-08-25 |
2016-03-22 |
Abraxis Bioscience Llc |
terapia de combinação com composições de nanopartículas de taxano e inibidores de hedgehog
|
|
US20110118298A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Infinity Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
|
|
CA3051495A1
(en)
|
2010-03-26 |
2011-09-29 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
|
KR20130028727A
(ko)
|
2010-03-29 |
2013-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 약물 전달 및 유효성 향상 방법
|
|
US9393318B2
(en)
|
2010-03-29 |
2016-07-19 |
Abraxis Bioscience, Llc |
Methods of treating cancer
|
|
CN103221042B
(zh)
|
2010-06-02 |
2016-02-10 |
阿布拉科斯生物科学有限公司 |
治疗膀胱癌的方法
|
|
AU2011261240A1
(en)
*
|
2010-06-03 |
2013-01-10 |
Abraxis Bioscience, Llc |
Use of the SPARC microenvironment signature in the treatment of cancer
|
|
KR20130088116A
(ko)
|
2010-06-04 |
2013-08-07 |
아브락시스 바이오사이언스, 엘엘씨 |
췌장암의 치료 방법
|
|
CA2801891C
(en)
|
2010-06-07 |
2020-10-27 |
Abraxis Bioscience, Llc |
Combination therapy methods for treating proliferative diseases
|
|
AU2012249371B2
(en)
|
2011-04-28 |
2017-06-08 |
Abraxis Bioscience, Llc |
Intravascular delivery of nanoparticle compositions and uses thereof
|
|
PL2790675T3
(pl)
|
2011-12-14 |
2019-12-31 |
Abraxis Bioscience, Llc |
Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US20140199404A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
US20140199405A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
JP6349381B2
(ja)
|
2013-03-12 |
2018-06-27 |
アブラクシス バイオサイエンス， エルエルシー |
肺がんを処置する方法
|
|
CN105209035A
(zh)
|
2013-03-13 |
2015-12-30 |
阿布拉科斯生物科学有限公司 |
治疗儿童实体瘤的方法
|
|
JP6309610B2
(ja)
|
2013-03-14 |
2018-04-11 |
アブラクシス バイオサイエンス， エルエルシー |
膀胱がんを処置する方法
|